Britta Otte

Intensive Supportive Care plus Immunosuppression in IgA Nephropathy

Thomas Rauen, Frank Eitner, Christina Fitzner et al. · New England Journal of Medicine · 2015 · 722 citations · Full text

Medicine, Internal Medicine, Nephrology +16

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

Antonio J. Vallejo‐Vaz, Christophe Stevens, Alexander R.M. Lyons et al. · The Lancet · 2021 · 305 citations · Full text

Public Health, Endocrinology, Genetics +13

Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy

Jonathan Barratt, Richard Lafayette, Jens Kristensen et al. · Kidney International · 2022 · 215 citations · Full text

Pharmacy, Nephrology, Pharmacotherapy +13

After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathy

Thomas Rauen, Stephanie Wied, Christina Fitzner et al. · Kidney International · 2020 · 202 citations · Full text

Medicine, Internal Medicine, Nephrology +8

Effects of Two Immunosuppressive Treatment Protocols for IgA Nephropathy

Thomas Rauen, Christina Fitzner, Frank Eitner et al. · Journal of the American Society of Nephrology · 2017 · 105 citations · Full text

Medicine, Immunology, Nephrology +17